XML 64 R7.htm IDEA: XBRL DOCUMENT v3.2.0.727
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Statement Of Cash Flows [Abstract]    
Net earnings available to common stockholders $ 125.3 $ 131.0
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities    
Depreciation and amortization 109.2 138.1
Share-based incentive compensation 33.2 [1] 26.4
Profit sharing expense 19.3 19.1
Amortization of senior debt related items and other 1.3 4.1
Loss on debt redemption and refinancing activities 111.3 0.8
Impairment on equity method investment   5.9
Asset impairment   4.2
Provisions for bad debt 2.3 3.6
Provisions for inventory obsolescence 1.4 5.7
Gain from Claims Settlement   (21.1)
Deferred taxes, net 4.3 6.3
Net (gain) loss on disposals of property and equipment and other (3.6) 0.2
Gain on sale of business (29.2)  
Remeasurement loss related to Venezuelan subsidiaries 29.7 14.8
Foreign currency (gains) (3.4) (0.3)
Other non-cash items 1.2 (4.5)
Changes in operating assets and liabilities:    
Trade receivables, net (47.9) (56.1)
Inventories (99.1) (97.8)
Other assets (50.4) (25.0)
Accounts payable 101.8 69.0
Settlement agreement and related items 235.2 (929.7)
Other liabilities (78.5) (50.5)
Net cash provided by (used in) operating activities 463.4 (755.8)
Cash flows from investing activities:    
Capital expenditures (57.6) (55.1)
Proceeds from sale of business 75.6  
Businesses acquired in purchase transactions, net of cash and cash equivalents acquired (8.5)  
Proceeds from sales of property, equipment and other assets 26.4 1.2
Settlement of foreign currency forward contracts 36.9 5.8
Net cash (used in) provided by investing activities 72.8 (48.1)
Cash flows from financing activities:    
Net proceeds from borrowings 68.6 362.2
Dividends paid on common stock (54.8) (56.0)
Acquisition of common stock for tax withholding obligations under our Omnibus stock plan and 2005 Contingent Stock Plan (7.4) (2.8)
Repurchases of common stock (149.7) (130.0)
Payments for debt extinguishment costs (108.3)  
Other financing activities (0.1) 0.1
Net cash provided by (used in) financing activities (251.7) 173.5
Effect of foreign currency exchange rate changes on cash and cash equivalents (37.9) (5.5)
Balance, beginning of period 322.6 [2] 992.4
Net change during the period 246.6 (635.9)
Balance, end of period 569.2 356.5
Supplemental Cash Flow Information:    
Interest payments, net of amounts capitalized 131.4 563.1
Income tax payments 52.8 41.2
Stock appreciation rights payments (less amounts included in restructuring payments) 18.3 17.0
Restructuring payments including associated costs 45.2 49.9
Non-cash items:    
Transfers of shares of our common stock from treasury for our 2014 and 2013 profit-sharing plan contributions $ 36.7 33.2
Transfer of shares of our common stock as part of the funding of the Settlement agreement   $ 1.8
[1] The amounts included above do not include the expense related to our U.S. profit sharing contributions made in the form of our common stock or the expense or income related to SARs and other cash-based awards. See Stock Appreciation Rights above for further details of SARs. At June 30, 2015, our other cash-based awards were not material to our condensed consolidated financial positions or results of operations.
[2] During the second quarter of 2015, we completed the sale of our North American foam trays and absorbent pads business. During the first quarter of 2015, the assets and liabilities met the criteria of held for sale classification. Accordingly, we reclassified $42 million of assets and $6 million of liabilities as held for sale as of December 31, 2014. Refer to Note 3, “Divestitures and Acquisitions” of the notes to condensed consolidated financial statements for further details.